echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > 2022 Gene Therapy Product Quality Control Research Advanced Seminar Notice

    2022 Gene Therapy Product Quality Control Research Advanced Seminar Notice

    • Last Update: 2022-08-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Notice on Holding the Advanced Seminar on "2022 Gene Therapy Product Quality Control Research and Non-clinical Safety Evaluation Strategies"
    July 29-31, 2022 Nanjing (simultaneous online live broadcast) 1.
    Conference arrangement 2.
    Conference lecturer and main content 3.
    Participants 4.
    Conference fee 5.
    Conference description 6.
    Contact 1848541789@qq.
    com

    China Chemical Enterprise Management Association Pharmaceutical Chemical Professional Committee
    Beijing Huaxia Kaisheng Pharmaceutical Technology Center
    June 2022

    Reference attachment: Participation Receipt Form
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.